| Typicality: | 0.470 |
| Saliency: | 0.515 |
| in relation to the approval | 4 | other |
| period → be prescribed by → regulation | 54 |
| period → be prescribed in → regulation | 11 |
| period → be prescribed under → this regulation | 3 |
| negative | neutral | positive |
| 0.135 | 0.820 | 0.045 |
| Raw frequency | 68 |
| Normalized frequency | 0.515 |
| Modifier score | 0.500 |
| Perplexity | 85.572 |